Delivery Order SPE2DB20D1100-SPE2DB24FC0M4
Award Date
5/31/24
Potential Completion Date
6/24/24
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENHERTU 100 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $21,614.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 9, 2024. The contract has a completion date of May 31, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $21,614.96, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS to the Defense Logistics Agency (DLA). The $32,422.44 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 16, 2024. The contract has a completion date of March 11, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $32,422.44, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is June 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, the prime contractor. The ceiling value of this firm fixed price delivery order contract is $5,403.74, and the ultimate completion date is June 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which...
This federal contract award is for the delivery of ENHERTU 100 MG VIALS to the U.S. Defense agency known as the Medical Supply Chain. The prime contractor for this $27,018.70 firm fixed price delivery order contract is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has an ultimate completion date of June 14, 2024 and was awarded on May 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $19,341.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENHERTU 100 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 mg vials. The $26,932.32 firm fixed-price contract has an ultimate completion date of January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENHERTU 100 mg vials. The contract has a ceiling value of $27,018.70 and an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ENHERTU 100 MG VIALS, a specialty pharmaceutical product, with a potential value of $16,211.22. The contract is a firm fixed price delivery order with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside...